Dali Mu

Dr. Dali Mu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Clinical Breast Cancer
Verified
Journal Article
Closed access
YLYan Lin
Yan Lin
YYYan Yang
Yan Yang
XZXiaoyu Zhang
Xiaoyu Zhang
WLWandi Li
Wandi Li
HLHaoran Li
Haoran Li
DMDali Mu
Dali Mu

1 July 2021 in Surgery
Verified
Journal Article
Closed access
YYYan Yang
Yan Yang
DMDali Mu
Dali Mu
BXBoyang Xu
Boyang Xu
WLWandi Li
Wandi Li
XZXiaoyu Zhang
Xiaoyu Zhang
HLHaoran Li
Haoran Li

15 December 2020 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
YLYan Ba Lin
Yan Ba Lin
YYYan Ma Yang
Yan Ma Yang
XZXiaoyu Ba Zhang
Xiaoyu Ba Zhang
WLWandi Ma Li
Wandi Ma Li
HLHaoran Ba Li
Haoran Ba Li
DMDali Mu
Dali Mu
Background: Breast hypertrophy is a chronic health problem. Until now, reduction mammaplasty is still a critical treatment for this disease. Given the publications, which reviewed the relationship between operation and quality of life, based on nonrandomized controlled studies and how low their quality are. Thus, we aimed to assess the effectiveness of reduction mammaplasty in improving health-related quality of life based on high-quality randomized-controlled trials. Method: A systematic search of the following databases: PubMed (MEDLINE), the Cochrane Library, the Cochrane Central Register of Controlled Trials, Web of Science, EMBASE, ClinicalTrials.gov, BIOSIS previews, and GreyNet. All the English publications have been searched without any restrictions of time, countries, or article type. Studies examining the effects of breast reduction versus control group on postoperative quality of life were included. Data on studies, patient characteristics, outcome measures were extracted. Statistical analysis was performed using Review Manager 5.3. Results: In all, 7 randomized-controlled trials involving 285 participants were included, in which 4 studies were pooled in the meta-analysis. Because of the effect of reduction mammaplasty, statistically significant improvements were found on pain (standardised mean difference [SMD], −1.29; 95% confidence interval [CI], −1.63 to −0.96; P < 0.00001), physical function (SMD, 0.97; 95% CI, 0.69–1.25; P < 0.00001) and psychological function (SMD, −0.79; 95% CI, −1.07 to −0.52; P < 0.00001). Conclusions: Our findings based on the randomized-controlled trials suggest that the quality of life of women undergoing breast reduction surgery is significantly improved. Reduction mammaplasty is an effective treatment for symptomatic breast hypertrophy.

23 March 2021 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
YYYan Yang
Yan Yang
DMDali Mu
Dali Mu
BXBoyang Xu
Boyang Xu
WLWandi Li
Wandi Li
XZXiaoyu Zhang
Xiaoyu Zhang
HLHaoran Li
Haoran Li

9 January 2020 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
XZXiaoyu Zhang
Xiaoyu Zhang
DMDali Mu
Dali Mu
YYYan Yang
Yan Yang
WLWandi Li
Wandi Li
YLYan Lin
Yan Lin
JLJie Luan
Jie Luan

4 January 2025 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
XZXiaoyu Zhang
Xiaoyu Zhang
YLYan Lin
Yan Lin
HLHaoran Li
Haoran Li
QWQian Wang
Qian Wang
DMDali Mu
Dali Mu